CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Eagle Pharmaceuticals, Inc.

For profitWebsite ↗

Also known as: Eagle Pharmaceuticals, Inc. | EAGLE PHARMS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Jul 22, 2023

Timeline

2000s

Jun 1, 2007
Eagle Pharmaceuticals, Inc.— Founded

2010s

Dec 7, 2015
bendamustine— NDA Secondary Org
Nov 11, 2016
Arsia Therapeutics— Acquired

2020s

Feb 8, 2020
pemetrexed— Marketing Organization

Drugs by trial phase (5 distinct, 7 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

cal02

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (6)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Arsia Therapeutics

Recent trials (11)

NCT05776004Study chairPhase 2Jul 22, 2023
NCT05776004Lead sponsorPhase 2Jul 22, 2023
NCT03600376Study directorPhase 3Aug 19, 2018
NCT03600376Lead sponsorPhase 3Aug 19, 2018
NCT03324061Lead sponsorPhase 1Nov 30, 2017
NCT03324061Study directorPhase 1Nov 30, 2017
NCT03189433Lead sponsorPhase 2Jul 1, 2017
NCT02513095Lead sponsorPhase 2Sep 1, 2015
NCT02513095Study directorPhase 2Sep 1, 2015
NCT02162888Lead sponsorPhase 1Nov 1, 2013
NCT01045018CollaboratorPhase 3Jan 1, 2008

Details

Founded: Woodcliff Lake, NJ, US Jun 1, 2007
Last known activity: Jul 22, 2023